LONG-TERM DEBT |
6 Months Ended |
|---|---|
Sep. 26, 2026 | |
| Debt Disclosure [Abstract] | |
| LONG-TERM DEBT | LONG-TERM DEBT In April 2026, the Company borrowed $13.0 million under the Credit Facility for the acquisitions of SCM Metrology and Laboratories S.A. and SCM Metrologia Honduras, S.A. (together, "SCM"). In June 2026, the Company repaid $2.5 million. In August 2026, the Company borrowed $6.5 million for the acquisition of Southeastern Biomedical Associates, LLC ("Southeastern"). As of September 26, 2026, $150.0 million was available for borrowing, subject to covenant restrictions, under the Credit Facility, of which $116.9 million was outstanding. Interest and Other Costs: The Company’s weighted average interest rate for the revolving credit facility for the three months ended September 26, 2026 was 5.2%. Covenants: The Company was in compliance with all financial covenants and requirements during and as of the six months ended September 26, 2026.
|